Kairos Pharma Ltd. (KAPA), a clinical-stage biopharmaceutical company, will be presenting a talk on its investigational compound KROS 101, which is under preclinical development. KROS 101 targets the GITR ligand and enables T cells to increase in numbers and kill cancer cells more effectively.
The following are some of the other biotech stocks making big moves in premarket trading today.
In the Green
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.